Overview

Progesterone and Brain Imaging Study

Status:
Active, not recruiting

Trial end date:
2022-12-01

Target enrollment:

Participant gender:

Summary

Male and female smokers were recruited to undergo 2 phases of smoking cessation. Each phase was 4 days long and involved 3 brain-imaging scans, blood draws and an intervention involving progesterone or a matched placebo.

Phase:

Phase 4

Details

Lead Sponsor:

University of Pennsylvania

Collaborator:

National Institute on Drug Abuse (NIDA)

Treatments:

Progesterone